Asensus Surgical, Inc.
ASXCAMEXHealthcare
$0.35
+$0.00(+0.64%)
Market Cap$94922082
P/E Ratio—
52W High$0.3993
52W Low$0.169
Asensus Surgical, Inc. (ASXC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ASXC · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2024Report Date: Aug 13, 2024EPS Actual
-$0.07
Est. -$0.05 · -40.0%
Revenue
$0.00B
Est. $0.00B · +79.4%
Fiscal Period
Q3 FY2024
FY ends December
Report Date
Aug 13, 2024
After Market Close
▼ Miss EPS▲ Beat Revenue
ASXC reports quarterly as a AMEX-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ▼ Q3 FY2024 | Aug 13, 2024 | -$0.05 | -$0.07 | -40.0% | $0.00B | $0.00B | +79.4% |
| ▼ Q2 FY2024 | May 14, 2024 | -$0.05 | -$0.07 | -40.0% | $0.00B | $0.00B | -6.4% |
| ▼ Q1 FY2024 | Mar 21, 2024 | -$0.05 | -$0.07 | -40.0% | $0.01B | $0.01B | +2.5% |
| ▲ Q4 FY2023 | Nov 14, 2023 | -$0.07 | -$0.06 | +14.3% | $0.00B | $0.00B | -70.6% |
| ▼ Q3 FY2023 | Aug 10, 2023 | -$0.08 | -$0.09 | -12.5% | $0.00B | $0.00B | +1.0% |
| ▼ Q2 FY2023 | May 11, 2023 | -$0.07 | -$0.09 | -28.6% | $0.00B | $0.00B | -51.2% |
| — Q1 FY2023 | Mar 2, 2023 | -$0.07 | -$0.07 | +0.0% | $0.00B | $0.00B | -29.5% |
| — Q4 FY2022 | Nov 10, 2022 | -$0.07 | -$0.07 | +0.0% | $0.00B | $0.00B | -12.2% |
Q3 FY2024
Aug 13, 2024Miss
EPS Actual
-$0.07
EPS Est.
-$0.05
EPS Surpr.
-40.0%
Revenue
$0.00B
Q2 FY2024
May 14, 2024Miss
EPS Actual
-$0.07
EPS Est.
-$0.05
EPS Surpr.
-40.0%
Revenue
$0.00B
Q1 FY2024
Mar 21, 2024Miss
EPS Actual
-$0.07
EPS Est.
-$0.05
EPS Surpr.
-40.0%
Revenue
$0.01B
Q4 FY2023
Nov 14, 2023Beat
EPS Actual
-$0.06
EPS Est.
-$0.07
EPS Surpr.
+14.3%
Revenue
$0.00B
Q3 FY2023
Aug 10, 2023Miss
EPS Actual
-$0.09
EPS Est.
-$0.08
EPS Surpr.
-12.5%
Revenue
$0.00B
Q2 FY2023
May 11, 2023Miss
EPS Actual
-$0.09
EPS Est.
-$0.07
EPS Surpr.
-28.6%
Revenue
$0.00B
Q1 FY2023
Mar 2, 2023
EPS Actual
-$0.07
EPS Est.
-$0.07
EPS Surpr.
+0.0%
Revenue
$0.00B
Q4 FY2022
Nov 10, 2022
EPS Actual
-$0.07
EPS Est.
-$0.07
EPS Surpr.
+0.0%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $-0.03 | $-0.03 | $-0.03 | 1 |
| Q3 FY2025 | $-0.03 | $-0.03 | $-0.03 | 1 |
| Q2 FY2025 | $-0.03 | $-0.03 | $-0.03 | 1 |
| Q1 FY2025 | $-0.03 | $-0.03 | $-0.03 | 1 |
| Q4 FY2024 | $-0.05 | $-0.05 | $-0.05 | 1 |
| Q3 FY2024 | $-0.06 | $-0.06 | $-0.06 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q3 FY2024 | Aug 13, 2024 | -40.0% | $0.32 | $0.32 | -0.03% |
| ▼ Q2 FY2024 | May 14, 2024 | -40.0% | $0.26 | $0.28 | +5.84% |
| ▼ Q1 FY2024 | Mar 21, 2024 | -40.0% | $0.29 | $0.28 | -2.78% |
| ▲ Q4 FY2023 | Nov 14, 2023 | +14.3% | $0.21 | $0.24 | +11.90% |
| ▼ Q3 FY2023 | Aug 10, 2023 | -12.5% | $0.33 | $0.33 | +0.21% |
| ▼ Q2 FY2023 | May 11, 2023 | -28.6% | $0.68 | $0.63 | -7.65% |
| ▲ Q1 FY2023 | Mar 2, 2023 | +0.0% | $0.69 | $0.69 | -0.28% |
| ▲ Q4 FY2022 | Nov 10, 2022 | +0.0% | $0.41 | $0.43 | +4.34% |
Q3 FY2024-0.03%
Report Date
Aug 13, 2024
EPS Beat/Miss
-40.0%
Price Before
$0.32
Price After
$0.32
Q2 FY2024+5.84%
Report Date
May 14, 2024
EPS Beat/Miss
-40.0%
Price Before
$0.26
Price After
$0.28
Q1 FY2024-2.78%
Report Date
Mar 21, 2024
EPS Beat/Miss
-40.0%
Price Before
$0.29
Price After
$0.28
Q4 FY2023+11.90%
Report Date
Nov 14, 2023
EPS Beat/Miss
+14.3%
Price Before
$0.21
Price After
$0.24
Q3 FY2023+0.21%
Report Date
Aug 10, 2023
EPS Beat/Miss
-12.5%
Price Before
$0.33
Price After
$0.33
Q2 FY2023-7.65%
Report Date
May 11, 2023
EPS Beat/Miss
-28.6%
Price Before
$0.68
Price After
$0.63
Q1 FY2023-0.28%
Report Date
Mar 2, 2023
EPS Beat/Miss
+0.0%
Price Before
$0.69
Price After
$0.69
Q4 FY2022+4.34%
Report Date
Nov 10, 2022
EPS Beat/Miss
+0.0%
Price Before
$0.41
Price After
$0.43
Avg Beat Reaction+5.32%
Avg Miss Reaction-0.88%
Beat Rate3 / 8 quarters
Largest Move+11.90% (Q4 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ASXC ends December
Asensus Surgical, Inc. (ASXC) most recently reported earnings on August 13, 2024 for Q3 FY2024, posting EPS of $-0.07 — missing the analyst consensus of $-0.05 by -40.0%. The next ASXC earnings date is expected around September 1, 2026.
Each quarter, investors track ASXC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ASXC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ASXC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ASXC earnings · 5 questionsAsensus Surgical, Inc.'s next earnings report is expected around September 1, 2026. ASXC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ASXC historically reports after market close (AMC).
ASXC earnings datewhen is ASXC earningsASXC next earnings datewhen does ASXC report earningsASXC earnings calendar
▸ Source: FMP · Asensus Surgical, Inc. SEC filings · US GAAP · Asensus Surgical, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026